Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000170938 | SCV000223498 | uncertain significance | not provided | 2024-12-12 | criteria provided, single submitter | clinical testing | Identified in a patient with sick sinus syndrome (SSS) in published literature; the variant was also identified in this patient's mother and brother who both had sinus bradycardia (PMID: 30196304); Identified in an individual with noncompaction cardiomyopathy (PMID: 30847666); A published functional study suggests slowed activation kinetics and reduced surface expression (PMID: 30196304); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30196304, 30847666) |
Ambry Genetics | RCV000619663 | SCV000737997 | uncertain significance | Cardiovascular phenotype | 2023-06-14 | criteria provided, single submitter | clinical testing | The p.R378C variant (also known as c.1132C>T), located in coding exon 2 of the HCN4 gene, results from a C to T substitution at nucleotide position 1132. The arginine at codon 378 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant has been detected in a proband with childhood onset sick sinus syndrome and in two relatives with bradycardia (Möller M et al. Cell Physiol Biochem. 2018 Sep;49(3):1197-1207). This variant has also been detected in an individual who underwent genetic testing for suspicion of noncompaction cardiomyopathy; however, details were limited (van Lint FHM et al. Neth Heart J. 2019 Jun;27(6):304-309). In vitro suggest this variant may impact channel function and protein cell-surface expression; however, additional evidence is needed to confirm these findings (Möller M et al. Cell Physiol Biochem. 2018 Sep;49(3):1197-1207). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001051690 | SCV001215858 | uncertain significance | Brugada syndrome 8 | 2022-04-11 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 378 of the HCN4 protein (p.Arg378Cys). This variant is present in population databases (rs758468167, gnomAD 0.01%). This missense change has been observed in individual(s) with sick sinus syndrome (PMID: 30196304). ClinVar contains an entry for this variant (Variation ID: 190779). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HCN4 protein function. Experimental studies have shown that this missense change affects HCN4 function (PMID: 30196304). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000170938 | SCV002563267 | likely pathogenic | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478538 | SCV002785975 | uncertain significance | Sick sinus syndrome 2, autosomal dominant; Brugada syndrome 8; Epilepsy, idiopathic generalized, susceptibility to, 18 | 2021-08-26 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV000170938 | SCV005198432 | uncertain significance | not provided | 2023-01-05 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000170938 | SCV001925478 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000170938 | SCV001957556 | uncertain significance | not provided | no assertion criteria provided | clinical testing |